<DOC>
	<DOCNO>NCT01250990</DOCNO>
	<brief_summary>This study look whether niacin improves reverse cholesterol transport ( RCT ) healthy volunteer . 3H-Cholesterol used measure RCT analyzing change tracer activity total plasma , lipoprotein , red blood cell ( RBCs ) stool . The hypothesis niacin augments reverse cholesterol transport .</brief_summary>
	<brief_title>Effect Niacin Transport HDL Relationship Atherogenic Lipoproteins Lipolysis</brief_title>
	<detailed_description>The study use 3H-cholesterol bound albumin ( particulate cholesterol ) ass ability high density lipoprotein ( HDL ) transport cholesterol liver eliminate . This process call Reverse Cholesterol transport one main mechanism HDL protect atherosclerotic cardiovascular disease . The availability method ass RCT important development new drug affect RCT may result useful treatment atherosclerosis . This study evaluate use radiolabeled particulate cholesterol administer intravenously association albumin , method study reverse cholesterol transport ( RCT ) humans treatment niacin analyzing change tracer activity total plasma lipoprotein . The study population healthy volunteer .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Men woman age 18 75 inclusive HDL cholesterol &gt; = 25 mg/dL subject , &lt; = 60 mg/dL men &lt; = 70 mg/dL woman Women must nonchildbearing potential . They must surgically sterilize least 6 month prior screen postmenopausal . Postmenopausal woman must regular menstrual bleeding least 2 year prior inclusion . Subjects must good overall health . Subjects must able comprehend willing provide sign Institutional Regulatory Board ( IRB ) approve Informed Consent Form . Subjects must willing comply studyrelated procedure . Subjects must weigh least 140 pound participate HDL kinetics Substudy . Clinicallymanifest cardiovascular disease , include coronary disease , cerebrovascular disease , peripheral vascular disease History diabetes mellitus fast glucose &gt; 126 mg/dL screen visit Presence New York Heart Association ( NYHA ) Class III IV chronic heart failure unstable angina pectoris History endocrine disease History nonskin malignancy within previous 5 year Anemia define hemoglobin less 12 g/dL Renal insufficiency define creatinine ³ 1.3 mg/dl Any major active rheumatologic , pulmonary , dermatologic disease inflammatory condition Uncontrolled hypertension ( Systolic &gt; 160 mm Hg and/or Diastolic &gt; 100 mmHg two consecutive measurement Use warfarin , know coagulopathy /or elevate Prothrombin time/Partial Thromboplastin Time ( PT/PTT ) &gt; 1.5 x upper limit normal ( ULN ) Selfreported history Human immunodeficiency virus ( HIV ) positive Previous organ transplantation Clinical evidence liver disease liver injury indicate abnormal liver function test Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 2x ULN , selfreported history positive Hepatitis B Hepatitis C Any major surgical procedure occur within previous 3 month screen visit History illicit drug abuse ( &lt; 1 year ) Regular use alcoholic beverage ( &gt; 2 drinks/day ) Body mass index ( BMI ) &gt; 35 kg/m2 &lt; 18.5 kg/m2 Administration investigational drug within 6 week prior screen visit Serious unstable medical psychological condition , opinion investigator , would compromise subject 's safety successful participation study exclude . Use daily lipidaltering therapy prior initiation study medication exclusionary following circumstance ( washout nonstatins permit ) : Statins within 4 week Niacin &gt; 250 mg/ day within 6 week : Advicor , Niaspan , Niacor , Simcor , SloNiacin , supplemental niacin Fibrates within 12 week : fenofibrate ( Antara , Lofibra , Tricor , Triglide ) , gemfibrozil ( Lopid ) , clofibrate Enterically active lipidaltering drug within 4 week : colestipol ( Colestid ) , cholestyramine ( Questran ) , colesevelam ( Welchol ) , ezetimibe ( Zetia , Vytorin ) , orlistat ( Xenical , Alli ) Red yeast rice Fish oil &gt; 2 g/day within 4 week : Lovaza ( née Omacor ) , numerous supplement Altered dose selective estrogen receptor modulator ( SERM ) within 4 week History severe intolerance niacin Men plan conceive child within 3 month conclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Niacin</keyword>
	<keyword>HDL</keyword>
	<keyword>Reverse cholesterol transport</keyword>
</DOC>